Previous Article | Next Article 
Molecular and Cellular Biology, February 2002, p. 886-900, Vol. 22, No. 3
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.22.3.886-900.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Gradient of E2A Activity in B-Cell Development
Sabine Herblot,1 Peter D. Aplan,2 and Trang Hoang3*
The Clinical Research Institute of Montréal, Montréal, Québec, Canada H2W 1R7,1
Genetics Department, Medicine Branch, Division of Clinical Science, National Cancer Institute, Gaithersburg, Maryland 20877,2
Departments of Pharmacology and Biochemistry and Molecular Biology Program, University of Montréal, Québec, Canada H3C 3J73
Received 30 May 2001/
Returned for modification 10 July 2001/
Accepted 6 November 2001
The E2A locus is a frequent target of chromosomal translocations in B-cell acute lymphoblastic leukemia (B-ALL). E2A encodes two products, E12 and E47, that are part of the basic helix-loop-helix (bHLH) family of transcription factors and are central in B lineage differentiation. E2A haplo-insufficiency hinders progression through three major checkpoints in B-cell development: commitment into the B lineage, at the pro-B to pre-B transition, and in the induction of immunoglobulin M (IgM) expression required for a functional BCR. These observations underscore the importance of E2A gene dosage in B-cell development. Here we show that a higher proportion of pro-B cells in E2A+/- mice is in the cell cycle compared to that in wild-type littermates. This increase correlates with lower p21waf/cip1 levels, indicating that E2A has an antiproliferative function in B-cell progenitors. Ectopic expression in the B lineage of SCL/Tal1, a tissue-specific bHLH factor that inhibits E2A function, blocks commitment into the B lineage without affecting progression through later stages of differentiation. Furthermore, ectopic SCL expression exacerbates E2A haplo-insufficiency in B-cell differentiation, indicating that SCL genetically interacts with E2A. Taken together, these observations provide evidence for a gradient of E2A activity that increases from the pre-pro-B to the pre-B stage and suggest a model in which low levels of E2A (as in pro-B cells) are sufficient to control cell growth, while high levels (in pre-B cells) are required for cell differentiation. The antiproliferative function of E2A further suggests that in B-ALL associated with t(1;19) and t(17;19), the disruption of one E2A allele contributes to leukemogenesis, in addition to other anomalies induced by E2A fusion proteins.
* Corresponding author. Mailing address: Institut de Recherches Cliniques de Montréal, 110 Ave. des Pins Ouest, Montréal, Québec H2W 1R7, Canada. Phone: (514) 987-5588. Fax: (514) 987-5757. E-mail:
hoangt{at}ircm.qc.ca.
Molecular and Cellular Biology, February 2002, p. 886-900, Vol. 22, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/MCB.22.3.886-900.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Yang, Q., Kardava, L., St. Leger, A., Martincic, K., Varnum-Finney, B., Bernstein, I. D., Milcarek, C., Borghesi, L.
(2008). E47 Controls the Developmental Integrity and Cell Cycle Quiescence of Multipotential Hematopoietic Progenitors. J. Immunol.
181: 5885-5894
[Abstract]
[Full Text]
-
Wojciechowski, J., Lai, A., Kondo, M., Zhuang, Y.
(2007). E2A and HEB Are Required to Block Thymocyte Proliferation Prior to Pre-TCR Expression. J. Immunol.
178: 5717-5726
[Abstract]
[Full Text]
-
King, A. M., Van der Put, E., Blomberg, B. B., Riley, R. L.
(2007). Accelerated Notch-Dependent Degradation of E47 Proteins in Aged B Cell Precursors Is Associated with Increased ERK MAPK Activation. J. Immunol.
178: 3521-3529
[Abstract]
[Full Text]
-
Wikstrom, I., Forssell, J., Goncalves, M., Colucci, F., Holmberg, D.
(2006). E2-2 Regulates the Expansion of Pro-B Cells and Follicular versus Marginal Zone Decisions. J. Immunol.
177: 6723-6729
[Abstract]
[Full Text]
-
de la Grange, P. B., Armstrong, F., Duval, V., Rouyez, M.-C., Goardon, N., Romeo, P.-H., Pflumio, F.
(2006). Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells. Blood
108: 2998-3004
[Abstract]
[Full Text]
-
Yamamoto, M., Hayashi, K., Nojima, T., Matsuzaki, Y., Kawano, Y., Karasuyama, H., Goitsuka, R., Kitamura, D.
(2006). BASH-novel PKC-Raf-1 pathway of pre-BCR signaling induces {kappa} gene rearrangement. Blood
108: 2703-2711
[Abstract]
[Full Text]
-
Lazorchak, A. S., Wojciechowski, J., Dai, M., Zhuang, Y.
(2006). E2A Promotes the Survival of Precursor and Mature B Lymphocytes. J. Immunol.
177: 2495-2504
[Abstract]
[Full Text]
-
Palamarchuk, A., Zanesi, N., Aqeilan, R. I., Efanov, A., Maximov, V., Santanam, U., Hagan, J. P., Croce, C. M., Pekarsky, Y.
(2006). Tal1 transgenic expression reveals absence of B lymphocytes.. Cancer Res.
66: 6014-6017
[Abstract]
[Full Text]
-
Capron, C., Lecluse, Y., Kaushik, A. L., Foudi, A., Lacout, C., Sekkai, D., Godin, I., Albagli, O., Poullion, I., Svinartchouk, F., Schanze, E., Vainchenker, W., Sablitzky, F., Bennaceur-Griscelli, A., Dumenil, D.
(2006). The SCL relative LYL-1 is required for fetal and adult hematopoietic stem cell function and B-cell differentiation. Blood
107: 4678-4686
[Abstract]
[Full Text]
-
Suh, H. C., Gooya, J., Renn, K., Friedman, A. D., Johnson, P. F., Keller, J. R.
(2006). C/EBP{alpha} determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood
107: 4308-4316
[Abstract]
[Full Text]
-
Lazorchak, A. S., Schlissel, M. S., Zhuang, Y.
(2006). E2A and IRF-4/Pip Promote Chromatin Modification and Transcription of the Immunoglobulin {kappa} Locus in Pre-B Cells. Mol. Cell. Biol.
26: 810-821
[Abstract]
[Full Text]
-
Reynaud, D., Ravet, E., Titeux, M., Mazurier, F., Renia, L., Dubart-Kupperschmitt, A., Romeo, P.-H., Pflumio, F.
(2005). SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood
106: 2318-2328
[Abstract]
[Full Text]
-
Bijl, J., Sauvageau, M., Thompson, A., Sauvageau, G.
(2005). High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia. Genes Dev.
19: 224-233
[Abstract]
[Full Text]
-
Song, S., Cooperman, J., Letting, D. L., Blobel, G. A., Choi, J. K.
(2004). Identification of Cyclin D3 as a Direct Target of E2A Using DamID. Mol. Cell. Biol.
24: 8790-8802
[Abstract]
[Full Text]
-
Van der Put, E., Frasca, D., King, A. M., Blomberg, B. B., Riley, R. L.
(2004). Decreased E47 in Senescent B Cell Precursors Is Stage Specific and Regulated Posttranslationally by Protein Turnover. J. Immunol.
173: 818-827
[Abstract]
[Full Text]
-
Curtis, D. J., Hall, M. A., Van Stekelenburg, L. J., Robb, L., Jane, S. M., Begley, C. G.
(2004). SCL is required for normal function of short-term repopulating hematopoietic stem cells. Blood
103: 3342-3348
[Abstract]
[Full Text]
-
Quong, M. W., Martensson, A., Langerak, A. W., Rivera, R. R., Nemazee, D., Murre, C.
(2004). Receptor Editing and Marginal Zone B Cell Development Are Regulated by the Helix-Loop-Helix Protein, E2A. JEM
199: 1101-1112
[Abstract]
[Full Text]
-
Kim, W., Kook, S., Kim, D. J., Teodorof, C., Song, W. K.
(2004). The 31-kDa Caspase-generated Cleavage Product of p130cas Functions as a Transcriptional Repressor of E2A in Apoptotic Cells. J. Biol. Chem.
279: 8333-8342
[Abstract]
[Full Text]
-
Kim, H.-J., Kim, J.-Y., Park, Y.-Y., Choi, H.-S.
(2003). Synergistic activation of the human orphan nuclear receptor SHP gene promoter by basic helix-loop-helix protein E2A and orphan nuclear receptor SF-1. Nucleic Acids Res
31: 6860-6872
[Abstract]
[Full Text]
-
de Candia, P., Solit, D. B., Giri, D., Brogi, E., Siegel, P. M., Olshen, A. B., Muller, W. J., Rosen, N., Benezra, R.
(2003). Angiogenesis impairment in Id-deficient mice cooperates with an Hsp90 inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc. Natl. Acad. Sci. USA
100: 12337-12342
[Abstract]
[Full Text]
-
Doan, L. L., Kitay, M. K., Yu, Q., Singer, A., Herblot, S., Hoang, T., Bear, S. E., Morse, H. C. III, Tsichlis, P. N., Grimes, H. L.
(2003). Growth Factor Independence-1B Expression Leads to Defects in T Cell Activation, IL-7 Receptor {alpha} Expression, and T Cell Lineage Commitment. J. Immunol.
170: 2356-2366
[Abstract]
[Full Text]
-
Wang, A., Gu, J., Judson-Kremer, K., Powell, K.L., Mistry, H., Simhambhatla, P., Aldaz, C. M., Gaddis, S., MacLeod, M. C.
(2003). Response of human mammary epithelial cells to DNA damage induced by BPDE: involvement of novel regulatory pathways. Carcinogenesis
24: 225-234
[Abstract]
[Full Text]
-
Bradney, C., Hjelmeland, M., Komatsu, Y., Yoshida, M., Yao, T.-P., Zhuang, Y.
(2003). Regulation of E2A Activities by Histone Acetyltransferases in B Lymphocyte Development. J. Biol. Chem.
278: 2370-2376
[Abstract]
[Full Text]
-
Frasca, D., Nguyen, D., Riley, R. L., Blomberg, B. B.
(2003). Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice. J. Immunol.
170: 719-726
[Abstract]
[Full Text]
-
Portis, T., Longnecker, R.
(2002). Epstein-Barr Virus LMP2A Interferes with Global Transcription Factor Regulation When Expressed during B-Lymphocyte Development. J. Virol.
77: 105-114
[Abstract]
[Full Text]
-
Lecuyer, E., Herblot, S., Saint-Denis, M., Martin, R., Begley, C. G., Porcher, C., Orkin, S. H., Hoang, T.
(2002). The SCL complex regulates c-kit expression in hematopoietic cells through functional interaction with Sp1. Blood
100: 2430-2440
[Abstract]
[Full Text]